Cresco Labs Announces $40M-Plus At-The-Market Offering

Cresco Labs Inc. (CSE: CL) (OTC: CRLBF) said Tuesday that it has signed an equity distribution agreement with Canaccord Genuity under which the company is authorized to sell up to CA$55 million ($41.3 million) of subordinate voting shares.

The company said it plans to use the net proceeds from the program to support general corporate activities, discretionary capital programs, potential acquisitions and repaying debt. 

Don’t miss out on the top cannabis …

Full story available on Benzinga.com

More Cresco Labs Announces $40M-Plus At-The-Market Offering